Cargando…

Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs)

Sarcopenia is characterized by loss of muscle mass, altered muscle composition, fat and fibrous tissue infiltration, and abnormal innervation, especially in older individuals with immune-mediated rheumatic diseases (IMRDs). Several techniques for measuring muscle mass, strength, and performance have...

Descripción completa

Detalles Bibliográficos
Autores principales: Salaffi, Fausto, Carotti, Marina, Di Matteo, Andrea, Ceccarelli, Luca, Farah, Sonia, Villota-Eraso, Catalina, Di Carlo, Marco, Giovagnoni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587967/
https://www.ncbi.nlm.nih.gov/pubmed/36125609
http://dx.doi.org/10.1007/s11547-022-01560-y
_version_ 1784814021623414784
author Salaffi, Fausto
Carotti, Marina
Di Matteo, Andrea
Ceccarelli, Luca
Farah, Sonia
Villota-Eraso, Catalina
Di Carlo, Marco
Giovagnoni, Andrea
author_facet Salaffi, Fausto
Carotti, Marina
Di Matteo, Andrea
Ceccarelli, Luca
Farah, Sonia
Villota-Eraso, Catalina
Di Carlo, Marco
Giovagnoni, Andrea
author_sort Salaffi, Fausto
collection PubMed
description Sarcopenia is characterized by loss of muscle mass, altered muscle composition, fat and fibrous tissue infiltration, and abnormal innervation, especially in older individuals with immune-mediated rheumatic diseases (IMRDs). Several techniques for measuring muscle mass, strength, and performance have emerged in recent decades. The portable dynamometer and gait speed represent the most frequently used tools for the evaluation of muscle strength and physical efficiency, respectively. Aside from dual-energy, X-ray, absorptiometry, and bioelectrical impedance analysis, ultrasound (US) and magnetic resonance imaging (MRI) techniques appear to have a potential role in evaluating muscle mass and composition. US and MRI have been shown to accurately identify sarcopenic biomarkers such as inflammation (edema), fatty infiltration (myosteatosis), alterations in muscle fibers, and muscular atrophy in patients with IMRDs. US is a low-cost, easy-to-use, and safe imaging method for assessing muscle mass, quality, architecture, and biomechanical function. This review summarizes the evidence for using US and MRI to assess sarcopenia.
format Online
Article
Text
id pubmed-9587967
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-95879672022-10-24 Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs) Salaffi, Fausto Carotti, Marina Di Matteo, Andrea Ceccarelli, Luca Farah, Sonia Villota-Eraso, Catalina Di Carlo, Marco Giovagnoni, Andrea Radiol Med Magnetic Resonance Imaging Sarcopenia is characterized by loss of muscle mass, altered muscle composition, fat and fibrous tissue infiltration, and abnormal innervation, especially in older individuals with immune-mediated rheumatic diseases (IMRDs). Several techniques for measuring muscle mass, strength, and performance have emerged in recent decades. The portable dynamometer and gait speed represent the most frequently used tools for the evaluation of muscle strength and physical efficiency, respectively. Aside from dual-energy, X-ray, absorptiometry, and bioelectrical impedance analysis, ultrasound (US) and magnetic resonance imaging (MRI) techniques appear to have a potential role in evaluating muscle mass and composition. US and MRI have been shown to accurately identify sarcopenic biomarkers such as inflammation (edema), fatty infiltration (myosteatosis), alterations in muscle fibers, and muscular atrophy in patients with IMRDs. US is a low-cost, easy-to-use, and safe imaging method for assessing muscle mass, quality, architecture, and biomechanical function. This review summarizes the evidence for using US and MRI to assess sarcopenia. Springer Milan 2022-09-20 2022 /pmc/articles/PMC9587967/ /pubmed/36125609 http://dx.doi.org/10.1007/s11547-022-01560-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Magnetic Resonance Imaging
Salaffi, Fausto
Carotti, Marina
Di Matteo, Andrea
Ceccarelli, Luca
Farah, Sonia
Villota-Eraso, Catalina
Di Carlo, Marco
Giovagnoni, Andrea
Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs)
title Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs)
title_full Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs)
title_fullStr Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs)
title_full_unstemmed Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs)
title_short Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs)
title_sort ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (imrds)
topic Magnetic Resonance Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587967/
https://www.ncbi.nlm.nih.gov/pubmed/36125609
http://dx.doi.org/10.1007/s11547-022-01560-y
work_keys_str_mv AT salaffifausto ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds
AT carottimarina ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds
AT dimatteoandrea ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds
AT ceccarelliluca ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds
AT farahsonia ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds
AT villotaerasocatalina ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds
AT dicarlomarco ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds
AT giovagnoniandrea ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds